Navamedic A (NAVA.OL) Stock Price

Navamedic A Price

Oslo Børs·CLOSED
12.95
​
Market closed

Revenue has compounded at 46.8% per year over the past 19 years to 565.36 M NOK. Earnings per share have declined at 18.9% per year over the last 15 years. Navamedic A's net margin stands at -4.2%, down from 0.2% several years earlier. Navamedic A currently offers a dividend yield of about 7.71%. Analysts set a median price target of 36.72 NOK, implying 183.6% above the current price. Of 7 analysts, 6 rate the stock a buy — an overall Buy consensus.

Navamedic A stock price

Access this data via the Eulerpool API

Navamedic A business model & stock analysis

Navamedic ASA engages in the delivery and marketing of pharmaceutical products to patients, hospitals, and pharmacies. The company is headquartered in Oslo, Oslo. The company went IPO on 2006-03-31. The company is a supplier of products delivered to hospitals and pharmacies. Navamedic’s product portfolio consists of prescription and Over The Counter (OTC) pharmaceuticals as well as other healthcare products registered as medical nutrition, medical devices, food supplements or cosmetics. The Company’s offering is divided into four product areas: Consumer Health, Specialty Pharma, Medical Nutrition and Branded Generics. The firm has one business segment which is the Pharma division. Navamedic ASA is present in all Nordic countries, the Baltics and Benelux. The firm has two subsidiaries, Navamedic AB, through which the Company distributes more than 40 products and a Norway-based Novicus Pharma AS.

Frequently asked questions about Navamedic A

Analysts currently set an average price target of 36.72 NOK for the Navamedic A stock (median: 36.72 NOK), implying +183.6 % versus the latest price. The consensus is based on 7 analyst ratings.

7 analysts currently rate the Navamedic A stock: 6 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Navamedic A to generate revenue of 569.85 M NOK and earnings per share of -0.15 NOK.

Converted at the current exchange rate, the Navamedic A share trades at 1.21 EUR (12.95 NOK).

The Navamedic A share (NAVA.OL) is listed on 6 stock exchanges, including: London (0FDB.L), Osaka (JPX) (NAVA.OL), Frankfurt (N1A.F), Stockholm (NAVA.ST).

The expected revenue of Navamedic A is 569.85 M NOK. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Navamedic A is -3.60 M NOK. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Navamedic A is currently -85.36. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Navamedic A stock.

The price-to-sales ratio (P/S) of Navamedic A is currently 0.54. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Navamedic A stock.

The Eulerpool Quality Score for Navamedic A is 3/10.

The ISIN of Navamedic A is NO0010205966. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Navamedic A is A0JKUU. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Navamedic A is NAVA.OL. The ticker symbol is used to trade Navamedic A shares on the stock exchange.

Fair ValueTerminal
13.47 NOK
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Pharmaceuticals
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Norway
Currency
NOK
Initial public offering
Mar 31, 2006
ISIN
NO0010205966
Cusip
R4685E104
Market capitalization
310.54 M NOKSmall Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2026
-85.36
P/Ee 2027
41.77
P/Ee 2028
12.45
P/S
P/Se
0.54
EV/EBIT
23.57
P/B Ratio
0.93
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-4.72 %
Dividend
Dividend yield
0.00 %
Est. Dividend Yield
7.71 %
Payout Ratio
0.00 %
Dividend growth Ø5Y
—
Dividend payments per year
1
Dividend paid since
0 years
Dividend not reduced since
0 years
Dividend increased since
0 years
Dividend withholding tax
25.00 %
Last updated Oct 8, 2026, 10:49 PM

Navamedic A Peer Group

Navamedic A Ticker

EURONEXT · NAVA.OLFRANKFURT · N1A.FLONDON · 0FDB.LOSE · NAVA.OLOSLO · NAVA.OLSTOCKHOLM · NAVA.ST

Navamedic A FIGI

NAVA:NO · BBG000DDCTF3N1A:GR · BBG000P1CM89N1A:GF · BBG000P1CN32N1A:GS · BBG000P1CR06N1A:GB · BBG000P1CSR5NAVA:EO · BBG000TN6DN7NAVA:XH · BBG000TN6G69NAVA:XC · BBG000TN6GH7NAVA:XF · BBG000TN6HK1NAVA:XE · BBG000TN6JV5NAVA:XJ · BBG000TN6JY2NAVA:XL · BBG000TN6K51